Global Cell And Gene Therapy Clinical Trial Supply, Demand and Key Producers, 2024-2030

Description

The global Cell And Gene Therapy Clinical Trial market size is expected to reach $ 37 million by 2030, rising at a market growth of 21.3% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The next generation of cell and gene therapies holds a significant promise for patients as an alternative treatment option or personalized medicine. Besides, the success rate of these products is also higher as compared to those for small-molecule products. This is due to the fact that CGT tends to target precise disease drivers rather than the broad targets for small-molecule therapy.

This report studies the global Cell And Gene Therapy Clinical Trial demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell And Gene Therapy Clinical Trial, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell And Gene Therapy Clinical Trial that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell And Gene Therapy Clinical Trial total market, 2019-2030, (USD Million)
Global Cell And Gene Therapy Clinical Trial total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell And Gene Therapy Clinical Trial total market, key domestic companies and share, (USD Million)
Global Cell And Gene Therapy Clinical Trial revenue by player and market share 2019-2024, (USD Million)
Global Cell And Gene Therapy Clinical Trial total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell And Gene Therapy Clinical Trial total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cell And Gene Therapy Clinical Trial market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, ICON Plc, Covance, Charles River Laboratory and PAREXEL International Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell And Gene Therapy Clinical Trial market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell And Gene Therapy Clinical Trial Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell And Gene Therapy Clinical Trial Market, Segmentation by Type
    Phase I
    Phase II
    Phase III
    Phase IV

Global Cell And Gene Therapy Clinical Trial Market, Segmentation by Application
    Oncology
    Cardiology
    CNS
    Musculoskeletal
    Infectious Diseases
    Dermatology
    Endocrine, Metabolic, Genetic
    Immunology & Inflammation
    Ophthalmology
    Others(Gastroenterology, Hematology,etc.)

Companies Profiled:
    IQVIA
    ICON Plc
    Covance
    Charles River Laboratory
    PAREXEL International Corporation

Key Questions Answered
1. How big is the global Cell And Gene Therapy Clinical Trial market?
2. What is the demand of the global Cell And Gene Therapy Clinical Trial market?
3. What is the year over year growth of the global Cell And Gene Therapy Clinical Trial market?
4. What is the total value of the global Cell And Gene Therapy Clinical Trial market?
5. Who are the major players in the global Cell And Gene Therapy Clinical Trial market?

Table of Contents

1 Supply Summary
    1.1 Cell And Gene Therapy Clinical Trial Introduction
    1.2 World Cell And Gene Therapy Clinical Trial Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell And Gene Therapy Clinical Trial Total Market by Region (by Headquarter Location)
        1.3.1 World Cell And Gene Therapy Clinical Trial Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.3 China Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.4 Europe Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.5 Japan Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.6 South Korea Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.7 ASEAN Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
        1.3.8 India Cell And Gene Therapy Clinical Trial Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell And Gene Therapy Clinical Trial Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell And Gene Therapy Clinical Trial Major Market Trends

2 Demand Summary
    2.1 World Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.2 World Cell And Gene Therapy Clinical Trial Consumption Value by Region
        2.2.1 World Cell And Gene Therapy Clinical Trial Consumption Value by Region (2019-2024)
        2.2.2 World Cell And Gene Therapy Clinical Trial Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.4 China Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.5 Europe Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.6 Japan Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.7 South Korea Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.8 ASEAN Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)
    2.9 India Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030)

3 World Cell And Gene Therapy Clinical Trial Companies Competitive Analysis
    3.1 World Cell And Gene Therapy Clinical Trial Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell And Gene Therapy Clinical Trial Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell And Gene Therapy Clinical Trial in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell And Gene Therapy Clinical Trial in 2023
    3.3 Cell And Gene Therapy Clinical Trial Company Evaluation Quadrant
    3.4 Cell And Gene Therapy Clinical Trial Market: Overall Company Footprint Analysis
        3.4.1 Cell And Gene Therapy Clinical Trial Market: Region Footprint
        3.4.2 Cell And Gene Therapy Clinical Trial Market: Company Product Type Footprint
        3.4.3 Cell And Gene Therapy Clinical Trial Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell And Gene Therapy Clinical Trial Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell And Gene Therapy Clinical Trial Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell And Gene Therapy Clinical Trial Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell And Gene Therapy Clinical Trial Consumption Value Comparison
        4.2.1 United States VS China: Cell And Gene Therapy Clinical Trial Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell And Gene Therapy Clinical Trial Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell And Gene Therapy Clinical Trial Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell And Gene Therapy Clinical Trial Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024)
    4.4 China Based Companies Cell And Gene Therapy Clinical Trial Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell And Gene Therapy Clinical Trial Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024)
    4.5 Rest of World Based Cell And Gene Therapy Clinical Trial Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell And Gene Therapy Clinical Trial Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cell And Gene Therapy Clinical Trial Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Phase I
        5.2.2 Phase II
        5.2.3 Phase III
        5.2.4 Phase IV
    5.3 Market Segment by Type
        5.3.1 World Cell And Gene Therapy Clinical Trial Market Size by Type (2019-2024)
        5.3.2 World Cell And Gene Therapy Clinical Trial Market Size by Type (2025-2030)
        5.3.3 World Cell And Gene Therapy Clinical Trial Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cell And Gene Therapy Clinical Trial Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Oncology
        6.2.2 Cardiology
        6.2.3 CNS
        6.2.4 Musculoskeletal
        6.2.5 Musculoskeletal
        6.2.6 Dermatology
        6.2.7 Endocrine, Metabolic, Genetic
        6.2.8 Immunology & Inflammation
        6.2.9 Ophthalmology
        6.2.10 Others(Gastroenterology, Hematology,etc.)
    6.3 Market Segment by Application
        6.3.1 World Cell And Gene Therapy Clinical Trial Market Size by Application (2019-2024)
        6.3.2 World Cell And Gene Therapy Clinical Trial Market Size by Application (2025-2030)
        6.3.3 World Cell And Gene Therapy Clinical Trial Market Size by Application (2019-2030)

7 Company Profiles
    7.1 IQVIA
        7.1.1 IQVIA Details
        7.1.2 IQVIA Major Business
        7.1.3 IQVIA Cell And Gene Therapy Clinical Trial Product and Services
        7.1.4 IQVIA Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 IQVIA Recent Developments/Updates
        7.1.6 IQVIA Competitive Strengths & Weaknesses
    7.2 ICON Plc
        7.2.1 ICON Plc Details
        7.2.2 ICON Plc Major Business
        7.2.3 ICON Plc Cell And Gene Therapy Clinical Trial Product and Services
        7.2.4 ICON Plc Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 ICON Plc Recent Developments/Updates
        7.2.6 ICON Plc Competitive Strengths & Weaknesses
    7.3 Covance
        7.3.1 Covance Details
        7.3.2 Covance Major Business
        7.3.3 Covance Cell And Gene Therapy Clinical Trial Product and Services
        7.3.4 Covance Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Covance Recent Developments/Updates
        7.3.6 Covance Competitive Strengths & Weaknesses
    7.4 Charles River Laboratory
        7.4.1 Charles River Laboratory Details
        7.4.2 Charles River Laboratory Major Business
        7.4.3 Charles River Laboratory Cell And Gene Therapy Clinical Trial Product and Services
        7.4.4 Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Charles River Laboratory Recent Developments/Updates
        7.4.6 Charles River Laboratory Competitive Strengths & Weaknesses
    7.5 PAREXEL International Corporation
        7.5.1 PAREXEL International Corporation Details
        7.5.2 PAREXEL International Corporation Major Business
        7.5.3 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Product and Services
        7.5.4 PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 PAREXEL International Corporation Recent Developments/Updates
        7.5.6 PAREXEL International Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell And Gene Therapy Clinical Trial Industry Chain
    8.2 Cell And Gene Therapy Clinical Trial Upstream Analysis
    8.3 Cell And Gene Therapy Clinical Trial Midstream Analysis
    8.4 Cell And Gene Therapy Clinical Trial Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell And Gene Therapy Clinical Trial Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cell And Gene Therapy Clinical Trial Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cell And Gene Therapy Clinical Trial Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cell And Gene Therapy Clinical Trial Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cell And Gene Therapy Clinical Trial Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell And Gene Therapy Clinical Trial Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cell And Gene Therapy Clinical Trial Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cell And Gene Therapy Clinical Trial Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cell And Gene Therapy Clinical Trial Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cell And Gene Therapy Clinical Trial Players in 2023
    Table 12. World Cell And Gene Therapy Clinical Trial Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cell And Gene Therapy Clinical Trial Company Evaluation Quadrant
    Table 14. Head Office of Key Cell And Gene Therapy Clinical Trial Player
    Table 15. Cell And Gene Therapy Clinical Trial Market: Company Product Type Footprint
    Table 16. Cell And Gene Therapy Clinical Trial Market: Company Product Application Footprint
    Table 17. Cell And Gene Therapy Clinical Trial Mergers & Acquisitions Activity
    Table 18. United States VS China Cell And Gene Therapy Clinical Trial Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cell And Gene Therapy Clinical Trial Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cell And Gene Therapy Clinical Trial Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cell And Gene Therapy Clinical Trial Revenue Market Share (2019-2024)
    Table 23. China Based Cell And Gene Therapy Clinical Trial Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cell And Gene Therapy Clinical Trial Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cell And Gene Therapy Clinical Trial Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell And Gene Therapy Clinical Trial Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cell And Gene Therapy Clinical Trial Revenue Market Share (2019-2024)
    Table 29. World Cell And Gene Therapy Clinical Trial Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cell And Gene Therapy Clinical Trial Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cell And Gene Therapy Clinical Trial Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cell And Gene Therapy Clinical Trial Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cell And Gene Therapy Clinical Trial Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cell And Gene Therapy Clinical Trial Market Size by Application (2025-2030) & (USD Million)
    Table 35. IQVIA Basic Information, Area Served and Competitors
    Table 36. IQVIA Major Business
    Table 37. IQVIA Cell And Gene Therapy Clinical Trial Product and Services
    Table 38. IQVIA Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. IQVIA Recent Developments/Updates
    Table 40. IQVIA Competitive Strengths & Weaknesses
    Table 41. ICON Plc Basic Information, Area Served and Competitors
    Table 42. ICON Plc Major Business
    Table 43. ICON Plc Cell And Gene Therapy Clinical Trial Product and Services
    Table 44. ICON Plc Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. ICON Plc Recent Developments/Updates
    Table 46. ICON Plc Competitive Strengths & Weaknesses
    Table 47. Covance Basic Information, Area Served and Competitors
    Table 48. Covance Major Business
    Table 49. Covance Cell And Gene Therapy Clinical Trial Product and Services
    Table 50. Covance Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Covance Recent Developments/Updates
    Table 52. Covance Competitive Strengths & Weaknesses
    Table 53. Charles River Laboratory Basic Information, Area Served and Competitors
    Table 54. Charles River Laboratory Major Business
    Table 55. Charles River Laboratory Cell And Gene Therapy Clinical Trial Product and Services
    Table 56. Charles River Laboratory Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Charles River Laboratory Recent Developments/Updates
    Table 58. PAREXEL International Corporation Basic Information, Area Served and Competitors
    Table 59. PAREXEL International Corporation Major Business
    Table 60. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Product and Services
    Table 61. PAREXEL International Corporation Cell And Gene Therapy Clinical Trial Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 62. Global Key Players of Cell And Gene Therapy Clinical Trial Upstream (Raw Materials)
    Table 63. Cell And Gene Therapy Clinical Trial Typical Customers
List of Figure
    Figure 1. Cell And Gene Therapy Clinical Trial Picture
    Figure 2. World Cell And Gene Therapy Clinical Trial Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cell And Gene Therapy Clinical Trial Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cell And Gene Therapy Clinical Trial Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell And Gene Therapy Clinical Trial Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cell And Gene Therapy Clinical Trial Revenue (2019-2030) & (USD Million)
    Figure 13. Cell And Gene Therapy Clinical Trial Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cell And Gene Therapy Clinical Trial Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cell And Gene Therapy Clinical Trial Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cell And Gene Therapy Clinical Trial by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell And Gene Therapy Clinical Trial Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell And Gene Therapy Clinical Trial Markets in 2023
    Figure 27. United States VS China: Cell And Gene Therapy Clinical Trial Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cell And Gene Therapy Clinical Trial Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cell And Gene Therapy Clinical Trial Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cell And Gene Therapy Clinical Trial Market Size Market Share by Type in 2023
    Figure 31. Phase I
    Figure 32. Phase II
    Figure 33. Phase III
    Figure 34. Phase IV
    Figure 35. World Cell And Gene Therapy Clinical Trial Market Size Market Share by Type (2019-2030)
    Figure 36. World Cell And Gene Therapy Clinical Trial Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Cell And Gene Therapy Clinical Trial Market Size Market Share by Application in 2023
    Figure 38. Oncology
    Figure 39. Cardiology
    Figure 40. CNS
    Figure 41. Musculoskeletal
    Figure 42. Infectious Diseases
    Figure 43. Dermatology
    Figure 44. Endocrine, Metabolic, Genetic
    Figure 45. Immunology & Inflammation
    Figure 46. Ophthalmology
    Figure 47. Cell And Gene Therapy Clinical Trial Industrial Chain
    Figure 48. Methodology
    Figure 49. Research Process and Data Source

Companies Mentioned

IQVIA
ICON Plc
Covance
Charles River Laboratory
PAREXEL International Corporation